Cancer and autoimmunity /

Saved in:
Bibliographic Details
Edition:1st ed.
Imprint:Amsterdam ; New York : Elsevier, 2000.
Description:xix, 446 p. : ill. ; 27 cm.
Language:English
Series:Autoantibody library
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4270674
Hidden Bibliographic Details
Other authors / contributors:Shoenfeld, Yehuda.
Gershwin, M. Eric, 1946-
ISBN:0444503315
Notes:Includes bibliographical references and index.
Table of Contents:
  • Preface
  • List of Contributors
  • Introduction: The Immune System, the Autoimmune State and Autoimmune Disease
  • Chapter I. Malignancies in Autoimmune Diseases
  • 1. Rheumatoid Arthritis and Cancer
  • 2. SLE and Cancer
  • 3. Malignancies Occurring in Scleroderma
  • 4. PSS (Scleroderma) and Cancer
  • 5. Vasculitis and Malignancy
  • 6. Sjogren's Syndrome and Lymphoproliferative Disease
  • 7. Polymyalgia Rheumatica, Temporal Arthritis and Occurrence of Malignant Tumors
  • 8. Myositis and Neoplasia
  • 9. Antiphospholipid Antibodies and Malignancies
  • 10. Malignancy in Coeliac Disease and Dermatitis Herpetiformis
  • 11. Autoimmune Rheumatic Diseases and Cancer: Evidence of Causality?
  • Chapter II. Autoimmunity in Malignant States
  • 1. Paraneoplastic Syndromes
  • 2. Paraneoplastic Arthritis
  • 3. Autoantibodies, Autoimmunity and Cancer
  • 4. Autonuclear Antibodies as Potential Markers of Lung Cancer
  • 5. Autoantibodies in Cancer Patients and in Persons with a Higher Risk of Cancer Development
  • 6. Autoantibodies to the Proliferation-Associated Nuclear Protein CENP-F in Cancer
  • 7. p53 Autoantibodies and Cancer: Specificity, Diagnosis and Monitoring
  • 8. Humoral Immune Response Against the Growth Suppressor p53 in Human Malignancies
  • 9. Expression of ETS Family of Genes in Systemic Lupus Erythematosis
  • 10. Immune Response to Tumor Stress Proteins-Implications for Vaccine Development Against Cancer
  • 11. Autoimmunity and B-Cell Malignancies
  • 12. Autoimmunity in B-Lymphoproliferative Disorders
  • 13. CD5 Positive B Cells: Crossroads of Autoimmunity and Lymphoid Malignancy
  • 14. Thymoma and Autoimmune Diseases
  • 15. Castleman's Disease and Autoimmunity
  • Chapter III. Mechanisms in Cancer and Autoimmunity
  • 1. IgA and Cancer
  • 2. Apoptosis: The Relation Between Anti-Fas Antibodies, and Immunosurveillance Against Cancer and Autoimmunity
  • 3. Hepatitis C Virus, Autoimmunity and Cancer
  • 4. The Human Neurotropic Virus, JCV, and Its Association with CNS Tumors
  • 5. The Smoking Cancer-Autoimmunity Connection
  • 6. Significance and Regulation of the Expression of MHC Class II Molecules on Autoimmune and Neoplastic Thyroid Cells
  • 7. Cancer Immunity: A Problem of Self-Tolerance
  • 8. Maternal Immune Response to Trophoblast, GTD, and Cancer
  • Chapter IV. Therapy in Autoimmunity and Cancer - Common and Different Denominators
  • 1. Therapy of Cancer and Autoimmunity: Immuno-modulatory Strategies Based on Modified Dendritic Cells
  • 2. Anti-Idiotypic Therapy in Autoimmunity
  • 3. Active Specific Immunotherapy of Malignant Diseases - Breaking Tolerance to Self-Antigens with Tumor Associated Antigen Mimics
  • 4. Antigen-Specific Antitumor Vaccination: Immunotherapy Versus Autoimmunity
  • 5. Bone-marrow Transplantation for Cancer and Autoimmunity
  • 6. Post-chemotherapy Rheumatism
  • 7. Cyclosporin and Cancer